The duality of the inflammatory response to traumatic brain injury

Molecular Neurobiology

Volumn 24, Issue 1-3, 2001, Pages 169-181

  Lenzlinger, Philipp M ^a,b   Morganti Kossmann, Maria Cristina ^b   Laurer, Helmut L ^a   McIntosh, Tracy K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Astrocytes; Blood brain barrier; Cytokines; Inflammation; Interleukin 6; Microglia; Neurons; Transforming growth factor ; Traumatic brain injury; Tumor necrosis factor

Indexed keywords

CHEMOTACTIC FACTOR; CYTOKINE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD CELL; BRAIN INJURY; BRAIN TISSUE; CELL DISRUPTION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DISABILITY; EDEMA; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; NERVE CELL; NEUROLOGIC DISEASE; SOCIOECONOMICS;

EID: 0035696441     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:24:1-3:169     Document Type: Article

References (108)

1. Impact of ICP instability and hypotension on outcome in patients with severe head trauma
2. Characterisation of brain edema following "controlled cortical impact injury" in rats
3. The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats
4. Serum extravasation and cytoskeletal alterations following traumatic brain injury in rats. Comparison of lateral fluid percussion and cortical impact models
5. Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury
6. The blood-brain barrier disruption to circulating proteins in the early period after fluid percussion brain injury in rats
7. Development of prolonged focal cerebral edema and regional cation changes following experimental brain injury in the rat
8. Experimental fluid percussion brain injury: Vascular disruption and neuronal and glial alterations
9. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: Relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function
10. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function
11. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury
12. Infammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury
13. Experimental closed head injury: Analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines
14. The association of leukocytes with secondary brain injury
15. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats
16. Up-regulation of intercellular adhesion molecule 1 in cerebral microvessels after cortical contusion trauma in a rat model
17. Intercellular adhesion molecule-1 expression on glia following brain injury: Participation of interleukin-1 beta
18. Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats
19. Cell-mediated immunity in severely head-injured patients: The role of suppressor lymphocytes and serum factors
20. Impairment of helper T-cell function following severe head injury
21. Suppression of cellular immune activity following severe head injury
22. Head injury: An immunologic deficit in T-cell activation
23. Extracranial complications of severe head injury
24. The blood-brain barrier and the inflammatory response
25. Intracerebral inflammation after human brain contusion
26. Intracerebral inflammatory response to experimental brain contusion
27. Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans
28. Altered immunoexpression of microglia and macrophages after mild head injury
29. Microglial response to transient focal cerebral ischemia: An immunocytochemical study on the rat cerebral cortex using antiphosphotyrosine antibody
30. Microglia: A sensor for pathological events in the CNS
31. Cellular inflammatory response after spinal cord injury in Sprague- Dawley and Lewis rats
32. Activation of microglia: A dangerous interlude in immune function in the brain
33. Brain macrophages: Evaluation of microglia and their functions
34. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia
35. Production of cytokines following brain injury: Beneficial and deleterious for the damaged tissue
36. Cytokines and metabolic dysfunction after severe head injury
37. Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma
38. Cytokines and the nervous system II: Actions and mechanisms of action
39. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children
40. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries
41. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barier dysfunction and nerve growth factor production
42. Elevation of tumor necrosis factor in head injury
43. The acute-phase response of the brain-injured patient
44. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury
45. Ventricular fluid interleukin-1 activity in patients with head injury
46. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury
47. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain
48. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS
49. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment
50. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue
51. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production
52. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand
53. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid
54. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10
55. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
56. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury
57. The presence of tumor necrosis factor in CSF and plasma after severe head injury
58. Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats
59. Astrogliosis in the neonatal and adult murine brain posttrauma: Elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma
60. Dual role of tumor necrosis factor alpha in brain injury
61. Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice
62. Evidence for two mechanisms by which tumor necrosis factor kills cells
63. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury
64. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury
65. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury
66. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes
67. Tumor necrosis factor-alpha modulates the proliferation of neural progenitors in the subventricular/ventricular zone of adult rat brain
68. NF-kappaB in neuronal plasticity and neurodegenerative disorders
69. Prolonged activation of NF-kappaB following traumatic brain injury in rats
70. Physiological and pathological roles of interleukin-6 in the central nervous system
71. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6
72. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains
73. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression
74. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases
75. Cytokine actions in the central nervous system
76. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons
77. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons
78. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes
79. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
80. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage
81. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice
82. Models of traumatic brain injury
83. Biphasic transforming growth factor-beta production flanking the pro-inflammatory cytokine response in cerebral trauma
84. Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures
85. Transforming growth factor-beta 1 (TGF-beta 1) expression and regulation in rat cortical astrocytes
86. Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta
87. Transforming growth factor beta: The good, the bad, and the ugly
88. TGF-beta 1 is an organizer of responses to neurodegeneration
89. The expression of transforming growth factor-beta1 (TGF-beta1) in hippocampal neurons: A temporary upregulated protein level after transient forebrain ischemia in the rat
90. Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats
91. Immune-mediated injury in bacterial meningitis
92. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury
93. Neuroprotective effects of TGF-beta 1
94. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS
95. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat
96. Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes
97. Rodent models of Alzheimer's disease: Rat A beta infusion approaches to amyloid deposits
98. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives
99. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies
100. Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease
101. Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease
102. Traumatic brain injury in rat produces changes of beta-amyloid precursor protein immunoreactivity
103. Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat
104. Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: An ovine head impact model
105. Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid
106. Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury
107. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid. Levels in mice overexpressing mutant amyloid precursor protein
108. Microglial interleukin-1 alpha expression in human head injury: Correlations with neuronal and neuritic beta-amyloid precursor protein expression